Dompe' Farmaceutici S.p.a.

Dompe S.p.a.

Rbs Pharma (roger Bellon Schoum) S.p.a.

Dimpe' Spa

Gaetano Clavenna

Carmelo A Gandolfi

Gianfranco Caselli

Marco Mantovanini

Piero Bellani

Claudio Omini

Lorella Cotini

Giorgio Poletti

Luigi Boltri

Rinaldo Pellegrini

Marcello Allegretti

Riccardo Bertini

Cinzia Bizzarri

Laura Brandolini

Enrico Bosone

Roberto Curti

Gabriella Melillo

Simonetta Fiorentino

Antonietta Coppola

Alberta Sosio

A new use of the enantiomer (R)-ketoprofen and of its salts with suitable organic and inorganic bases in the therapy of neutrophil-dependent diseases and phlogistic processes is described as well as pharmaceutical preparations containing such compounds and useful for oral, parenteral or topical administration.

(R)-2-(3-benzoylphenyl) propionic acid salts and pharmaceutical

Compounds of formula I: ##STR1## wherein R.sub.a, R.sub.b, .PHI., B and R are as defined in the disclosure, have antagonistic activity on osteoclast hyper-reactivity.

Geminal carboxylic acids and esters thereof pharmaceutical formulations

Parenteral pharmaceutical compositions containing ammoniomalkyl salts of

The present invention relates to a topical formulation of gel-like consistency, but nebulizable by a mechanical pump, containing colloidal silices as gelifying agent.

Pharmaceutical formulations in form of thixotropic gel

Salts of 2-(3-benzoylphenyl) propionic acid with organic bases and

Tartronic acid acetalic ethers and esters of the general formula: ##STR1## are provided and are useful in treatment of bone dysmetabolism. As examples, Ra and Rb may be hydrogen, B is a C.sub.2 -C.sub.12 acyl group, R is phenyl and n is 0-12.

Tartronic acids, their acetalic ethers and o-esters

Tartronic acids, their acetalic ethers and O-esters

A hydrophile pharmaceutical composition in the form of foam is described which contains as active ingredient Ketoprofen lysine salt having a concentration between 10 and 20% p/volume of solution which allows, for topic treatment, the maximum absorption of the active principle. The foam is applied for the local treatment in painful and phlogistic conditions, of rheumatic or traumatic nature, of the articulations, of the musles, of the tendons and of the ligaments.

Method of reducing subcutaneous inflammation by the topical application

Hydrophilic pharmaceutical composition containing ketoprofen lysine salt

A new use of N-(4'-pyridyl)-3,3-diphenylpropyl amine, known as fenpyramin, as platelet aggregation-inhibiting medicine and antithrombotic agent as well as vasodilating and antianginous medicine is described.

Use of fenpyramin as platelet-antiaggregating, vasodilating,

New imidazopyridine derivatives are described, having the following formula: ##STR1## wherein R represents a hydrogen atom, an alkyl radical of 1 to 3 carbon atoms, a methoxy group or a halogen atom,

Imidazopyridine compounds

Growing community of inventors

Milan, Italy

Gaetano Clavenna